These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 1988235)
21. Association of microalbuminuria with slow acetylator phenotype in type 1 diabetes mellitus. Madácsy L; Szórády I; Sánta A; Barkai L; Vámosi I Child Nephrol Urol; 1992; 12(4):192-6. PubMed ID: 1473091 [TBL] [Abstract][Full Text] [Related]
22. Caffeine as a potential indicator for acetylator status. Rankin RB; Hudson SA; Fell AF J Clin Pharm Ther; 1987 Feb; 12(1):47-51. PubMed ID: 3449563 [TBL] [Abstract][Full Text] [Related]
23. An alternative test for acetylator phenotyping with caffeine. Tang BK; Kadar D; Kalow W Clin Pharmacol Ther; 1987 Nov; 42(5):509-13. PubMed ID: 3677540 [TBL] [Abstract][Full Text] [Related]
24. Lack of association between slow acetylator status and spontaneous lupus erythematosus. Kumana CR; Chan MM; Wong KL; Wong RW; Kou M; Lauder IJ Clin Pharmacol Ther; 1990 Aug; 48(2):208-13. PubMed ID: 2379389 [TBL] [Abstract][Full Text] [Related]
26. Studies on N-Acetyltransferase (NAT2) Genotype Relationships in Emiratis: Confirmation of the Existence of Phenotype Variation among Slow Acetylators. Al-Ahmad MM; Amir N; Dhanasekaran S; John A; Abdulrazzaq YM; Ali BR; Bastaki S Ann Hum Genet; 2017 Sep; 81(5):190-196. PubMed ID: 28653770 [TBL] [Abstract][Full Text] [Related]
27. Segregation analyses of four urinary caffeine metabolite ratios implicated in the determination of human acetylation phenotypes. Vincent-Viry M; Pontes ZB; Gueguen R; Galteau MM; Siest G Genet Epidemiol; 1994; 11(2):115-29. PubMed ID: 8013893 [TBL] [Abstract][Full Text] [Related]
28. Practical issues in the management of hypersensitivity reactions: sulfonamides. Tilles SA South Med J; 2001 Aug; 94(8):817-24. PubMed ID: 11549195 [TBL] [Abstract][Full Text] [Related]
29. N-acetylator variability in Down's syndrome: characterization with caffeine. Morris ME; Griener JC; Msall ME Clin Pharmacol Ther; 1989 Sep; 46(3):359-66. PubMed ID: 2528436 [TBL] [Abstract][Full Text] [Related]
30. N-acetyltransferase 2 polymorphism in patients infected with human immunodeficiency virus. Kaufmann GR; Wenk M; Taeschner W; Peterli B; Gyr K; Meyer UA; Haefeli WE Clin Pharmacol Ther; 1996 Jul; 60(1):62-7. PubMed ID: 8689813 [TBL] [Abstract][Full Text] [Related]
31. Acetylation polymorphism of caffeine in a Japanese population. Hashiguchi M; Ebihara A Clin Pharmacol Ther; 1992 Sep; 52(3):274-6. PubMed ID: 1526084 [TBL] [Abstract][Full Text] [Related]
32. Acetylator phenotyping of tuberculosis patients using matrix isoniazid or sulphadimidine and its prognostic significance for treatment with several intermittent isoniazid-containing regimens. Ellard GA; Gammon PT Br J Clin Pharmacol; 1977 Feb; 4(1):5-14. PubMed ID: 843424 [TBL] [Abstract][Full Text] [Related]
34. Relationship between metabolic phenotype of N-acetylation and bladder cancer. Cui X; Guo R; Xu Z; Wang B; Li C Chin Med J (Engl); 2000 Apr; 113(4):303-5. PubMed ID: 11775223 [TBL] [Abstract][Full Text] [Related]
35. Drug-induced hypothyroidism: the thyroid as a target organ in hypersensitivity reactions to anticonvulsants and sulfonamides. Gupta A; Eggo MC; Uetrecht JP; Cribb AE; Daneman D; Rieder MJ; Shear NH; Cannon M; Spielberg SP Clin Pharmacol Ther; 1992 Jan; 51(1):56-67. PubMed ID: 1732077 [TBL] [Abstract][Full Text] [Related]
36. N-acetylation genotype and risk of severe reactions to sulphonamides in AIDS patients. Deloménie C; Grant DM; Mathelier-Fusade P; Jacomet C; Leynadier F; Jacqz-Aigrain E; Rozenbaum W; Krishnamoorthy R; Dupret JM Br J Clin Pharmacol; 1994 Dec; 38(6):581-2. PubMed ID: 7888297 [No Abstract] [Full Text] [Related]
37. Survey of the human acetylator polymorphism in spontaneous disorders. Evans DA J Med Genet; 1984 Aug; 21(4):243-53. PubMed ID: 6387123 [TBL] [Abstract][Full Text] [Related]
38. Aminopyrine metabolism in man: the acetylation of aminoantipyrine cosegregates with acetylation of caffeine. Agúndez JA; Carrillo JA; Martínez C; Benítez J Ther Drug Monit; 1995 Feb; 17(1):1-5. PubMed ID: 7725368 [TBL] [Abstract][Full Text] [Related]
39. N-acetyl-transferase phenotype and risk for preeclampsia. Zusterzeel PL; te Morsche RH; Raijmakers MT; Roes EM; Peters WH; Steegers-Theunissen RP; Steegers EA Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 1):797-802. PubMed ID: 16150277 [TBL] [Abstract][Full Text] [Related]